Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 32 results.
User Information
Export Records
  1. 1.   Leveraging long-acting IL-15 agonists for intratumoral delivery and enhanced antimetastatic activity
  2. Hangasky, John A; Fernández, Rocío Del Valle; Stellas,Dimitris; Hails, Guillermo; Karaliota,Sevasti; Ashley, Gary W; Felber,Barbara; Pavlakis,George; Santi, Daniel V
  3. Frontiers in Immunology. 2024, Nov 4; 15: 1458145.
  1. 2.   High baseline frequencies of natural killer cells are associated with asymptomatic SARS-CoV-2 infection
  2. Graydon, Elizabeth K; Malloy, Allison M W; Machmach, Kawthar; Sun, Peifang; Paquin-Proulx, Dominic; Lizewski, Stephen; Lizewski, Rhonda; Weir, Dawn L; Goforth, Carl W; Anderson,Steve; Letizia, Andrew G; Mitre, Edward
  3. Current Research in Immunology. 2023, Jul 15; 4: 100064.
  1. 3.   Natural Killer Cells Regulate Acute SIV Replication, Dissemination, and Inflammation, but Do Not Impact Independent Transmission Events
  2. Woolley, Griffin; Mosher, Matthew; Kroll, Kyle; Jones, Rhianna; Hueber, Brady; Sugawara, Sho; Manickam, Cordelia; Terry, Karen; Varner, Valerie; Lifton, Michelle; Ram, Daniel; Fennessey,Christine; Keele,Brandon; Reeves, R Keith
  3. Journal of Virology. 2022, Dec 13; e0151922.
  1. 4.   Natural Killer Cell Receptors and Ligands Are Associated With Markers of HIV-1 Persistence in Chronically Infected ART Suppressed Patients
  2. Ivison, Geoffrey T; Vendrame, Elena; Martínez-Colón, Giovanny J; Ranganath, Thanmayi; Vergara, Rosemary; Zhao, Nancy Q; Martin,Pat; Bendall, Sean C; Carrington,Mary; Cyktor, Joshua C; McMahon, Deborah K; Eron, Joseph; Jones, R Brad; Mellors, John W; Bosch, Ronald J; Gandhi, Rajesh T; Holmes, Susan; Blish, Catherine A
  3. Frontiers in Cellular and Infection Microbiology. 2022 12: 757846.
  1. 5.   Adaptive Admixture of HLA Class I Allotypes Enhanced Genetically Determined Strength of Natural Killer Cells in East Asians
  2. Deng, Zhihui; Zhen, Jianxin; Harrison, Genelle F.; Zhang, Guobin; Chen, Rui; Sun, Ge; Yu, Qiong; Nemat-Gorgani, Neda; Guethlein, Lisbeth A.; He, Liumei; Tang, Mingzhong; Gao, Xiaojiang; Cai, Siqi; Palmer, William H.; Shortt, Jonathan A.; Gignoux, Christopher R.; Carrington,Mary; Zou, Hongyan; Parham, Peter; Hong, Wenxu; Norman, Paul J.
  3. Molecular Biology and Evolution. 2021, May 19; 38(6): 2582-2596.
  1. 6.   CD47 Expression in Natural Killer Cells Regulates Homeostasis and Modulates Immune Response to Lymphocytic Choriomeningitis Virus
  2. Nath, Pulak Ranjan; Gangaplara, Arunakumar; Pal-Nath, Dipasmita; Mandal, Ajeet; Maric, Dragan; Sipes, John M.; Cam, Maggie; Shevach, Ethan M.; Roberts, David D.
  3. FRONTIERS IN IMMUNOLOGY. 2018, Dec 20; 9
  1. 7.   HIV-1-Mediated Downmodulation of HLA-C Impacts Target Cell Recognition and Antiviral Activity of NK Cells
  2. Körner, Christian; Simoneau, Camille R; Schommers, Philipp; Granoff, Mitchell; Ziegler, Maja; Hölzemer, Angelique; Lunemann, Sebastian; Chukwukelu, Janet; Corleis, Björn; Naranbhai, Vivek; Kwon, Douglas S; Scully, Eileen P; Jost, Stephanie; Kirchhoff, Frank; Carrington, Mary; Altfeld, Marcus
  3. Cell Host & Microbe. 2017, Jul 12; 22(1): 111-+.
  1. 8.   Distribution of killer cell immunoglobulin-like receptor genes in the mestizo population from Venezuela
  2. Conesa, A.; Fernandez-Mestre, M.; Padron, D.; Toro, F.; Silva, N.; Tassinari, P.; Blanca, I.; Martin, M. P.; Carrington, M.; Layrisse, Z.
  3. Tissue Antigens. 2010, Jun; 75(6): 724-729.
  1. 9.   Identification and analysis of novel transcripts and promoters in the human killer cell immunoglobulin-like receptor (KIR) genes
  2. Li, H.; Wright, P. W.; Anderson, S. K.
  3. Methods in molecular biology (Clifton, N.J.). 2010 612: 377-91.
  1. 10.   In vivo expression of signaling proteins in reconstituted NK cells
  2. Orr, S. J.; Quigley, L.; McVicar, D. W.
  3. Journal of Immunological Methods. 2009 340(2): 158-163.
  1. 11.   Ly49 cluster sequence analysis in a mouse model of diabetes: an expanded repertoire of activating receptors in the NOD genome
  2. Belanger, S.; Tai, L. H.; Anderson, S. K.; Makrigiannis, A. P.
  3. Genes and Immunity. 2008 9(6): 509-521.
  1. 12.   KIR and disease: a model system or system of models?
  2. Khakoo, S. I.; Carrington, M.
  3. Immunological Reviews. 2006, Dec; 214: 186-201.
  1. 13.   Regulation of class I major histocompatibility complex receptor expression in natural killer cells: one promoter is not enough!
  2. Pascal, V.; Stulberg, M. J.; Anderson, S. K.
  3. Immunological Reviews. 2006, Dec; 214: 9-21.
  1. 14.   Biology of natural killer cells: What is the relationship between natural killer cells and cancer? Will an increased number and/or function of natural killer cells result in lower cancer incidence?
  2. Anderson, S. K.
  3. Journal of Nutrition. 2005, DEC; 135(12): 2910S-2910S.
  1. 15.   Antiviral synergism
  2. Carrington, M.
  3. Nature Genetics. 2005, JUN; 37(6): 565-566.
  1. 16.   Fixation and cryopreservation of whole blood and isolated mononuclear cells: Influence of different procedures on lymphocyte subset analysis by flow cytometry
  2. Pinto, L. A.; Trivett, M. T.; Wallace, D.; Higgins, J.; Baseler, M.; Terabe, M.; Belyakov, I. M.; Berzofsky, J. A.; Hildesheim, A.
  3. Cytometry Part B-Clinical Cytometry. 2005, JAN; 63B(1): 47-55.
  1. 17.   Peroxisome proliferator-activated receptor-gamma and its ligands attenuate biologic functions of human natural killer cells
  2. Zhang, X.; Rodriguez-Galan, M. C.; Subleski, J. J.; Ortaldo, J. R.; Hodge, D. L.; Wang, J. M.; Shimozato, O.; Reynolds, D. A.; Young, H. A.
  3. Blood. 2004, NOV 15; 104(10): 3276-3284.
  1. 18.   Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success
  2. Hiby, S. E.; Walker, J. J.; O'Shaughnessy, K. M.; Redman, C. W. G.; Carrington, M.; Trowsdale, J.; Moffett, A.
  3. Journal of Experimental Medicine. 2004, OCT 18; 200(8): 957-965.
  1. 19.   Virally stimulated plasmacytoid dendritic cells produce chemokines and induce migration of T and NK cells
  2. Megjugorac, N. J.; Young, H. A.; Amrute, S. B.; Olshalsky, S. L.; Fitzgerald-Bocarsly, P.
  3. Journal of Leukocyte Biology. 2004 75(3): 504-514.
  1. 20.   Interleukin-15 gene therapy exclusively increases natural killer cells and suppresses tumor metastasis
  2. Yazawa, H.; Ortaldo, J.; Back, T.; Subleski, J.; Wiltrout, R.; Watanabe, M.
  3. Faseb Journal. 2004 18(5, Suppl. S): A1152-A1152.
  1. 21.   DNA methylation maintains allele-specific KTR gene expression in human natural killer cells
  2. Chan, H. W.; Kurago, Z. B.; Stewart, C. A.; Wilson, M. J.; Martin, M. P.; Mace, B. E.; Carrington, M.; Trowsdale, J.; Lutz, C. T.
  3. Journal of Experimental Medicine. 2003 197(2): 245-255.
  1. 22.   Natural killer cells are persistently infected and resistant to direct killing by HIV-1
  2. Valentin, A.; Pavlakis, G. N.
  3. Anticancer Research. 2003 23(3A): 2071-2075.
  1. 23.   Transgenic expression in mouse lung reveals distinct biological roles for the adenovirus type 5 E1A 243-and 289-amino-acid proteins
  2. Yang, Y. P.; McKerlie, C.; Borenstein, S. H.; Lu, Z.; Schito, M.; Chamberlain, J. W.; Buchwald, M.
  3. Journal of Virology. 2002 76(17): 8910-8919.
  1. 24.   Augmentation of antitumor effects by NK cell inhibitory receptor blockade in vitro and in vivo
  2. Koh, C. Y.; Blazar, B. R.; George, T.; Welniak, L. A.; Capitini, C. M.; Raziuddin, A.; Murphy, W. J.; Bennett, M.
  3. Blood. 2001 97(10): 3132-3137.
  1. 25.   T-cell adoptive therapy of tumors: Mechanisms of improved therapeutic performance
  2. Cohen, P. A.; Peng, L. M.; Kjaergaard, J.; Plautz, G. E.; Finke, J. H.; Koski, G. K.; Czerniecki, B. J.; Shu, S. Y.
  3. Critical Reviews in Immunology. 2001 21(1-3): 215-248.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel